J.ChadDavisMD

Pediatrics • Galveston, TX

Pediatric Critical Care Medicine

Physician

Join to view full profile

Are you Dr. Davis?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
301 University Blvd
Galveston, TX 77555
Phone+1 409-772-0817

Fax+1 409-772-0885
Is this information wrong?

Summary

Dr. J. Davis, MD is a pediatrician in Galveston, Texas. He is currently licensed to practice medicine in Texas, Kentucky, and North Carolina. He is affiliated with University of Texas Medical Branch.

Education & Training

Duke University HospitalFellowship, Pediatric Critical Care Medicine, 1998 - 2001
University of Texas Medical Branch HospitalsResidency, Pediatrics, 1994 - 1997
University of Texas Medical Branch School of MedicineClass of 1994

Certifications & Licensure

TX State Medical License 1997 - 2024
KY State Medical License 2001 - 2005
NC State Medical License 1998 - 2002

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Publications & Presentations

PubMed

Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis.
Henderson, C., Davis, J. C.> ;Nat Clin Pract Rheumatol. 2006 Apr
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for...
Revicki, D. A., Luo, M. P., Wordsworth, P., Wong, R. L., Chen, N., Davis, J. C.> ;J Rheumatol. 2008 Jul
Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures i...
Wanders, A. J., Gorman, J. D., Davis, J. C., Landewe, R. B., van der Heijde, D. M.> ;Arthritis Rheum. 2004 Feb 15
Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy.
Davis, J. C., van der Heijde, D., Dougados, M., Woolley, J. M.> ;Arthritis Rheum. 2005 Aug 15
Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis.
Davis, J. C.> ;Semin Arthritis Rheum. 2005 Feb
Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
Gorman, J. D., Sack, K. E., Davis, J. C.> ;N Engl J Med. 2002 May 2
Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
Davis, J. C., Revicki, D., van der Heijde, D. M., Rentz, A. M., Wong, R. L., Kupper, H., Luo, M. P.> ;Arthritis Rheum. 2007 Aug 15
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.
Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., Ouwehand, W. H., Samani, N. J., Todd, J. ...> ;Nat Genet. 2007 Nov
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis.
Gladman, D. D., Inman, R. D., Cook, R. J., Maksymowych, W. P., Braun, J., Davis, J. C., Landewé, R. B., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, ...> ;J Rheumatol. 2007 Aug
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures.
Gladman, D. D., Inman, R. D., Cook, R. J., van der Heijde, D., Landewé, R. B., Braun, J., Davis, J. C., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, ...> ;J Rheumatol. 2007 Aug
Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
Ward, M. M., Bruckel, J., Colbert, R., Doedhar, A., Emerson, C., Genant, H., Gladman, D. D., Inman, R., Reveille, J. D., Sandborg, C., Weisman, M. H., Davis, J. C.> ;J Rheumatol. 2006 May
2006 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
Khan, M. A., Clegg, D. O., Deodhar, A. A., Gabriel, S., Gaston, J. S., Hirsch, R., Ostergaard, M., Reveille, J. D., Turkiewicz, A. M., Weisman, M. H., Davis, J. C.> ;J Rheumatol. 2007 May
MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis.
Bredella, M. A., Steinbach, L. S., Morgan, S., Ward, M., Davis, J. C.> ;AJR Am J Roentgenol. 2006 Dec
Etanercept in adult patients with early onset ankylosing spondylitis.
Inman, R. D., Clegg, D. O., Davis, J. C., Whitmore, J. B., Solinger, A.> ;J Rheumatol. 2006 Aug
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Davis, J. C., Van Der Heijde, D., Braun, J., Dougados, M., Cush, J., Clegg, D. O., Kivitz, A., Fleischmann, R., Inman, R., Tsuji, W.> ;Arthritis Rheum. 2003 Nov
New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
Davis, J. C., Huang, F., Maksymowych, W.> ;Rheum Dis Clin North Am. 2003 Aug
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
Davis, J. C., Van der Heijde, D. M., Dougados, M., Braun, J., Cush, J. J., Clegg, D. O., Inman, R. D., de Vries, T., Tsuji, W. H.> ;J Rheumatol. 2005 Sep
Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
Maksymowych, W. P., Poole, A. R., Hiebert, L., Webb, A., Ionescu, M., Lobanok, T., King, L., Davis, J. C.> ;J Rheumatol. 2005 Oct
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
van der Heijde, D., Kivitz, A., Schiff, M. H., Sieper, J., Dijkmans, B. A., Braun, J., Dougados, M., Reveille, J. D., Wong, R. L., Kupper, H., Davis, J. C.> ;Arthritis Rheum. 2006 Jul
Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial.
Dougados, M., Luo, M. P., Maksymowych, W. P., Chmiel, J. J., Chen, N., Wong, R. L., Davis, J. C., van der Heijde, D.> ;Arthritis Rheum. 2008 Apr 15
Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.
Ward, M. M., Reveille, J. D., Learch, T. J., Davis, J. C., Weisman, M. H.> ;Arthritis Rheum. 2008 Jun 15
Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis.
Ward, M. M., Hendrey, M. R., Malley, J. D., Learch, T. J., Davis, J. C., Reveille, J. D., Weisman, M. H.> ;Arthritis Rheum. 2009 Jul 15
Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.
Ward, M. M., Weisman, M. H., Davis, J. C., Reveille, J. D.> ;Arthritis Rheum. 2005 Oct 15
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.
Lee, W., Reveille, J. D., Davis, J. C., Learch, T. J., Ward, M. M., Weisman, M. H.> ;Ann Rheum Dis. 2007 May
Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis.
Brionez, T. F., Assassi, S., Reveille, J. D., Learch, T. J., Diekman, L., Ward, M. M., Davis, J. C., Weisman, M. H., Nicassio, P.> ;Arthritis Res Ther. 2009 Dec 09
Join now to see all

Hospital Affiliations

University of Texas Medical BranchGalveston, Texas